Results 171 to 180 of about 97,874 (310)
Dysphagia and Esophageal Ulceration in Crohn’s Disease
M Gelfand, Charles L. Krone
openalex +1 more source
Primary Adenocarcinoma in an Enterocutaneous Fistula Associated with Crohn’s Disease [PDF]
Luis T Ying+4 more
openalex +1 more source
This article evaluates the therapeutic potential of extracellular vesicle‐like particles derived from Chinese herbal medicine (CHM‐EVLP) for a range of diseases. It underscores the significance of traditional Chinese medicine in the development of innovative formulations.
Ying‐qi Cao+6 more
wiley +1 more source
A Gastroenterologist’s Perspective of The Medical Management of Patients with Crohn’s Disease and Ulcerative Colitis [PDF]
ABR Thomson
openalex +1 more source
Abstract There are no data evaluating the success rate in transitioning intravenous (IV) to subcutaneous (SQ) risankizumab‐rzaa. To address these challenges, the University of Chicago Medicine (UCM) utilized an interprofessional team‐based, pharmacist‐directed follow‐up strategy to ensure patients initiate and maintain therapy.
David Choi+4 more
wiley +1 more source
No Evidence for Decreased Lymphocyte Reactivity in Crohn’s Disease
A. Graham Bird, Sven Britton
openalex +1 more source
Presenting sample demographics. Summary of the main features of CD patients from which adCD-MSCs were isolated. Data for healthy donors from which adHD-MSCs were isolated for the comparison of biological properties are also shown. (DOC 34 kb)
Forte, Dorian+14 more
openaire +1 more source
In this study, we aimed for the first time to demonstrate biotin interference in ELISA research kits used in the analysis of pediatric obesity parameters other than routine testing. Our study revealed that biotin interaction may occur in manual ELISA kits and may cause erroneous test results.
Ezgi Kürkçü Kahraman+4 more
wiley +1 more source
Reply of the authors: Growth Retardation in Crohn’s Disease
Theodore M. Bayless, Peter F. Whitington
openalex +1 more source